Chemoinformaics analysis of 3-Mercapto-2-methylpentan-1-ol
| Molecular Weight | 134.244 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.132 | nRig | 4 |
| Exact Molecular Weight | 134.077 | nRing | 0 |
| Solubility: LogS | -6.213 | nHRing | 0 |
| Solubility: LogP | 12.092 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 23.0571 |
| nHD | 2 | BPOL | 16.5049 |
| QED | 0.044 |
| Synth | 2.681 |
| Natural Product Likeliness | 0.501 |
| NR-PPAR-gamma | 0.217 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.999 |
| HIA | 0.009 |
| CACO-2 | -5.067 |
| MDCK | 0.0000111 |
| BBB | 0.003 |
| PPB | 1.02424 |
| VDSS | 2.187 |
| FU | 0.0117361 |
| CYP1A2-inh | 0.049 |
| CYP1A2-sub | 0.117 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.035 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.978 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.014 |
| CYP3a4-inh | 0.249 |
| CYP3a4-sub | 0.016 |
| CL | 5.502 |
| T12 | 0.084 |
| hERG | 0.286 |
| Ames | 0.005 |
| ROA | 0.003 |
| SkinSen | 0.99 |
| Carcinogencity | 0.114 |
| EI | 0.19 |
| Respiratory | 0.203 |
| NR-Aromatase | 0.205 |
| Antiviral | No |
| Prediction | 0.951689 |